Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec.
Categories
Recent Posts
- The Hidden Costs of Caregiving: What They Are and How Family Caregivers Can Manage Them
- FDA Issues Complete Response Letter for Deramiocel
- FDA declines to approve Capricor’s deramiocel for the treatment of Duchenne
- Becoming a grandmother, and daring to dream of a future for my sons
- Beyond the Clinic: How an MDA Grant Is Helping People with ALS Access Assistive Technology Earlier
Archive
- November 2026
- October 2026
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
